Rosiglitazone effects on cardiovascular risk factors and ischemia

被引：0
|
作者：
Raji, A
Di Carli, M
Seidl, K
Stone, P
Plutzky, J
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A472 / A472
页数：1
相关论文
共 50 条
  • [21] DIABETES Breaking news! Rosiglitazone and cardiovascular risk
    Kaul, Sanjay
    Diamond, George A.
    NATURE REVIEWS CARDIOLOGY, 2010, 7 (12) : 670 - 672
  • [22] Is rosiglitazone associated with increased risk for cardiovascular events?
    Markolf Hanefeld
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 648 - 649
  • [23] The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk
    Yee, M. S.
    Pavitt, D. V.
    Dhanjil, S.
    Godsland, I. F.
    Richmond, W.
    Johnston, D. G.
    DIABETIC MEDICINE, 2010, 27 (12) : 1392 - 1400
  • [24] EFFECTS OF RAMADAN FASTING ON CARDIOVASCULAR RISK FACTORS
    Norouzy, A.
    Nematy, M.
    Alinezhad-Namaghi, M.
    Shakhskalaee, M.
    Mozhdehifard, M.
    Sajjadi, S.
    Sabery, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 48 - 49
  • [25] Effects of physical exercise on cardiovascular risk factors
    Anedda, A.
    Penco, M.
    Vona, M.
    Bonetti, A.
    MEDICINA DELLO SPORT, 2006, 59 (02) : 195 - 202
  • [26] CARDIOVASCULAR RISK-FACTORS AND THE EFFECTS OF INTERVENTION
    SLEIGHT, P
    AMERICAN HEART JOURNAL, 1991, 121 (03) : 990 - 995
  • [27] THE EFFECTS OF METFORMIN ON CARDIOVASCULAR RISK-FACTORS
    GRANT, PJ
    DIABETES-METABOLISM REVIEWS, 1995, 11 : S43 - S50
  • [28] Rosiglitazone improves cardiovascular risk factors and insulin resistance in insulin-resistant nondiabetic Brazilian subjects
    Bahia, L
    Godoy-Matos, AF
    Bottino, DA
    Dorigo, D
    Aguiar, LGK
    Villela, N
    Bouskela, E
    DIABETES, 2004, 53 : A482 - A482
  • [29] Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning
    Ferdinandy, Peter
    Schulz, Rainer
    Baxter, Gary F.
    PHARMACOLOGICAL REVIEWS, 2007, 59 (04) : 418 - 458
  • [30] Use of rosiglitazone and pioglitazone immediately after the cardiovascular risk warnings
    Jain, Rahul
    Mullins, C. Daniel
    Lee, Helen
    Wong, Winston
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2012, 8 (01): : 47 - 59
12345